Pegfilgrastim-induced large vessel vasculitis.
作者信息
Saito Hiroaki, Suda Tsuyoshi, Oishi Naoki, Matsushita Eiki
机构信息
Internal Medicine, Kanazawa Municipal Hospital, Kanazawa, Ishikawa, Japan.
Internal Medicine, Kanazawa Municipal Hospital, Kanazawa, Ishikawa, Japan
出版信息
BMJ Case Rep. 2021 Jun 2;14(6):e243757. doi: 10.1136/bcr-2021-243757.
Abstract
摘要
相似文献
1
Pegfilgrastim-induced large vessel vasculitis.
BMJ Case Rep. 2021 Jun 2;14(6):e243757. doi: 10.1136/bcr-2021-243757.
2
Pegfilgrastim-associated large-vessel vasculitis developed during adjuvant chemotherapy for breast cancer: A case report and review of the literature.
J Oncol Pharm Pract. 2020 Oct;26(7):1785-1790. doi: 10.1177/1078155220910800. Epub 2020 Mar 18.
3
Large-vessel vasculitis induced by pegfilgrastim.
Acta Reumatol Port. 2021 Oct-Dec;46(4):355-359.
4
Pseudogout Attack after Pegfilgrastim Administration in Anaplastic Large Cell Lymphoma.
Intern Med. 2018 Jun 15;57(12):1779-1782. doi: 10.2169/internalmedicine.9362-17. Epub 2018 Feb 9.
5
[Diffuse large B-cell lymphoma complicated with drug-induced vasculitis during administration of pegfilgrastim].
Rinsho Ketsueki. 2017;58(11):2238-2242. doi: 10.11406/rinketsu.58.2238.
6
Localized Pegfilgrastim-induced Neutrophilic Dermatosis with Tissue G-CSF Expression: A Mimicker of Sweet's Syndrome.
Acta Derm Venereol. 2019 Jun 1;99(7):685-686. doi: 10.2340/00015555-3170.
7
Granulocyte-colony stimulating factor-associated aortitis in a woman with advanced breast cancer: a case report and review of the literature.
BMC Cancer. 2019 Dec 16;19(1):1217. doi: 10.1186/s12885-019-6403-9.
8
Pegfilgrastim: a granulocyte colony-stimulating factor with sustained duration of action.
Expert Opin Biol Ther. 2005 Dec;5(12):1635-46. doi: 10.1517/14712598.5.12.1635.
9
Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstim.
Cancer Med. 2020 Sep;9(17):6102-6110. doi: 10.1002/cam4.3261. Epub 2020 Jul 7.
10
Large-vessel vasculitis associated with PEGylated granulocyte-colony stimulating factor.
Neth J Med. 2019 Aug;77(6):224-226.
引用本文的文献
1
Literature review analysis of aortitis induced by granulocyte-colony stimulating factor.
Front Pharmacol. 2024 Dec 18;15:1487501. doi: 10.3389/fphar.2024.1487501. eCollection 2024.
2
A Case of Revelation Due to Pegfilgrastim.
Cureus. 2024 Jul 3;16(7):e63777. doi: 10.7759/cureus.63777. eCollection 2024 Jul.
3
Pegfilgrastim-induced vasculitis of the subclavian and basilar artery complicated by subarachnoid hemorrhage in a breast cancer patient: a case report and review of the literature.
Surg Case Rep. 2022 Aug 12;8(1):155. doi: 10.1186/s40792-022-01499-2.
4
Case Report: Vasculitis Triggered by SIRT in a Patient With Previously Untreated Cholangiocarcinoma.
Front Oncol. 2021 Dec 16;11:755750. doi: 10.3389/fonc.2021.755750. eCollection 2021.
本文引用的文献
1
The incidence and clinical features of PEGylated filgrastim-induced acute aortitis in patients with breast cancer.
Sci Rep. 2020 Oct 29;10(1):18647. doi: 10.1038/s41598-020-75620-6.
2
Granulocyte colony-stimulating factor- and chemotherapy-induced large-vessel vasculitis: six patient cases and a systematic literature review.
Rheumatol Adv Pract. 2020 Feb 6;4(1):rkaa004. doi: 10.1093/rap/rkaa004. eCollection 2020.
3
Granulocyte-colony stimulating factor-associated aortitis in a woman with advanced breast cancer: a case report and review of the literature.
BMC Cancer. 2019 Dec 16;19(1):1217. doi: 10.1186/s12885-019-6403-9.
4
Thoracic aortitis and aortic dissection following pegfilgrastim administration.
Eur J Cardiothorac Surg. 2017 Nov 1;52(5):993-994. doi: 10.1093/ejcts/ezx165.
5
Isolated abdominal aortitis following administration of granulocyte colony stimulating factor (G-CSF).
Clin Rheumatol. 2016 Jun;35(6):1655-7. doi: 10.1007/s10067-016-3253-6. Epub 2016 Apr 19.
Zotero 插件